1 Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies-National Polytechnic Institute (CINVESTAV-IPN), Mexico City, Mexico.
2 Nanomalaria Joint Unit, Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-University of Barcelona), Barcelona, Spain.
3 Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Barcelona, Spain.
4 University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-Center for Infection and Immunity of Lille, Lille, France.